Security Reports > Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc
Data Breaches, Cyber Attacks and Security Report
https://avadel.com ᛫ Biotech & Pharmaceuticals
Last updated August 3, 2020
https://avadel.com ᛫ Biotech & Pharmaceuticals
Last updated August 3, 2020
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Avadel Pharmaceuticals plc is implementing good security practices.
Avadel Pharmaceuticals plc NASDAQ: AVDL, is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results. Avadel markets products in the hospital and primary care spaces.
This report shows a preliminary security rating for Avadel Pharmaceuticals plc. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.
Get a deeper scan →Read more about the latest issues in cybersecurity
Compare Avadel Pharmaceuticals plc's security performance with other companies